In recent years, the idea that Roaccutane could slim down the nose has been widely circulating on social media, to the point that some people even speak of "Accutane rhinoplasty". This hypothesis is based on a biologically plausible mechanism: isotretinoin markedly reduces the activity and size of the sebaceous glands and decreases sebum production, which gradually leads to a thinning of the skin, particularly in individuals with thick, oily skin. As the skin of the nose contains numerous sebaceous glands, some patients feel that their nose appears slightly slimmer during the course of treatment.
Several scientific studies have indeed observed changes in the thickness of the skin of the nose under isotretinoin. For example, a study carried out in 40 patients with acne treated with isotretinoin (0.25 or 0.5 mg/kg/day) for four months assessed the thickness of the nasal skin by ultrasound. The results showed a significant decrease in the thickness of the dermis and subcutaneous tissue in different areas of the nose, regardless of the dose used. At the same time, elastography measurements revealed an increase in skin elasticity at the fourth month of treatment, suggesting an improvement in certain mechanical properties of the skin. However, the study did not include post-treatment follow-up: it is therefore not known what happens six, eight or twelve months after stopping Roaccutane.
That said, these observations are of particular interest to surgeons in the context of rhinoplasty. In patients with thick nasal skin, isotretinoin can sometimes be used before or after the operation to improve the definition of the nasal contours. A scientific review published in 2024 suggests that the use of isotretinoin around the time of surgery could improve patients’ aesthetic satisfaction during the six months following the procedure. However, the results remain variable: only a few studies report a lasting benefit beyond one year, and the protocols used differ markedly from one study to another. The authors emphasise that the scientific evidence remains limited, in particular because of the small sample sizes and the lack of long-term follow-up.
It is therefore important to emphasise that, although certain changes to the skin of the nose may occur during treatment with isotretinoin, this medicine is not intended to alter the shape of the nose.
Roaccutane remains above all a medical treatment for severe acne, prescribed within a specific dermatological context and under medical supervision. In certain particular situations, such as rhinophyma, the reduction in sebaceous gland activity may improve the appearance of the skin. However, isotretinoin must never be used for a purely aesthetic purpose, and its benefit–risk balance must always be assessed by a healthcare professional.